Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1548357312
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
11914 Astoria Blvd. #330
Houston, TX, 77089
Phone (281) 922-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
1,695 services
Medicare patients, 2024
503
Average age 74
Drug cost, 2024
$4.8M
11,322 prescriptions
Company payments, 2025
$882
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir A Hassan was code 99214 (office e&m - established), 1,193 times for 468 patients. In total Amir A Hassan billed 1,695 services in 19 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,193 | 468 | $93.81 | $112K |
| 90661 Vaccine Product | Office | 97 | 97 | $36.11 | $3,503 |
| G0008 Administration of influenza virus vaccine | Office | 97 | 97 | $32.75 | $3,177 |
| 99213 Office E&M - Established | Office | 93 | 74 | $68.96 | $6,413 |
| 99204 Office E&M - New | Office | 45 | 45 | $127.60 | $5,742 |
| 77080 Standard X-ray | Office | 36 | 35 | $39.96 | $1,439 |
By year: 2022 $132K for 1,732 services; 2023 $126K for 1,572 services; 2024 $134K for 1,695 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amir A Hassan prescribed most often to Medicare patients was Levothyroxine Sodium, with 924 prescriptions and refills. In total Amir A Hassan wrote 11,322 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 924 | 2,700 | 290 | $15K |
| Ozempic Semaglutide | 782 | 1,413 | 196 | $1.3M |
| Glimepiride Generic | 620 | 1,816 | 203 | $7,895 |
| Atorvastatin Calcium Generic | 580 | 1,701 | 197 | $6,209 |
| Metformin Hcl Er Metformin Hcl | 522 | 1,540 | 176 | $6,935 |
| Rosuvastatin Calcium Generic | 449 | 1,322 | 147 | $6,732 |
| Pravastatin Sodium Generic | 417 | 1,227 | 149 | $7,341 |
| Ezetimibe Generic | 369 | 1,084 | 131 | $13K |
| Amlodipine Besylate Generic | 305 | 899 | 105 | $2,254 |
| Mounjaro Tirzepatide | 293 | 429 | 76 | $452K |
| Lisinopril Generic | 263 | 776 | 83 | $2,234 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 258 | 593 | 78 | $336K |
| Vascepa Icosapent Ethyl | 196 | 549 | 74 | $186K |
| Jardiance Empagliflozin | 185 | 472 | 53 | $261K |
| Gabapentin Generic | 179 | 503 | 69 | $3,904 |
Brand drugs: 3,788 claims; generic drugs: 7,270 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir A Hassan $882 ($882 in general payments such as food, travel and fees) from 22 companies. The largest payer was Stryker Corporation with $140.
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation SYK | 1 | $140 |
| Novo Nordisk Inc NVO | 5 | $108 |
| Amgen Inc. AMGN | 5 | $94.54 |
| Janssen Biotech, Inc. JNJ | 2 | $57.7 |
| Insulet Corporation PODD | 1 | $57.25 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $46.84 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $44.32 |
| Dexcom, Inc. DXCM | 2 | $37.92 |
| Abbvie Inc. ABBV | 2 | $36.8 |
| UCB, Inc. UCB.BR | 2 | $35.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.